See All Slides - tctmd.com

Slides

Presentation THT 2025

Role of Molecular Biopsy in Precision Rejection Diagnosis

Presenter: Andrea Fernandez-Valledor

February 12, 2025

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Presentation THT 2025

Debate: Biopsy Is the Gold Standard for Rejection Screening

Presenter: Maryjane Farr

February 12, 2025

Presentation THT 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Diaphragmatic Stimulation - Viscardia

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Greater Splanchnic Nerve Ablation for HFpEF

Presenter: Sheldon Litwin

February 12, 2025

Presentation THT 2025

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Performance of a Remote Speech Analysis Technology to Detect Worsening Heart Failure Events in Ambulatory Patients With Heart Failure

Presenter: William Abraham

February 12, 2025

Presentation THT 2025

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Presenter: Simon Braumann

February 12, 2025

Advertisement

Slides

Role of Molecular Biopsy in Precision Rejection Diagnosis

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Debate: Biopsy Is the Gold Standard for Rejection Screening

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Diaphragmatic Stimulation - Viscardia

Greater Splanchnic Nerve Ablation for HFpEF

Effects of AtrioVentricular Interval Modulation (AVIM) Therapy in Subjects With Hypertension and Diastolic Dysfunction

Overview of Residual Risk and Pathophysiological Targets for Devices to Treat Chronic HF

Performance of a Remote Speech Analysis Technology to Detect Worsening Heart Failure Events in Ambulatory Patients With Heart Failure

Myeloperoxidase Inhibition in Patients With Ischemic or Non-Ischemic Cardiomyopathy and Heart Failure With Reduced Ejection Fraction (MYSTERY-HF)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content